Pagina 11 di 20

Re: RICERCA SCIENTIFICA OMEOPATICA

MessaggioInviato: gio nov 08, 2012 2:14 am
di Dr.Ascani
Homeopathic Treatment of Anal Fissures using Nitricum acidum

Abstract:
The authors used randomized clinical experimentation that was controlled by a double-blind versus placebo challenge to evaluate the therapeutic activity of Nitricum acidum 9 CH on anal fissures. In general, the active treatment appeared to be satisfactory, but was statistically significant only in two of the 6 parameters considered: burning sensation and the subjective opinion of the patient regarding the efficacy of the treatment.

Fonte:
Bignamini M, Saruggia M, Sansonetti G. Homeopathic Treatment of Anal Fissures using Nitricum acidum Berlin Journal on Research in Homoeopathy, 1, 4/5, 286-287, December 1991

Re: RICERCA SCIENTIFICA OMEOPATICA

MessaggioInviato: gio nov 08, 2012 2:16 am
di Dr.Ascani
Homoeopathic Treatment of Migraine

In this randomised, placebo controlled double blind study, 60 people suffering from migraine were treated using constitutional homoeopathy over a period of 4 months. Those patients in the control group experienced a reduction in migraine frequency from 9.9 attacks per month to 7.9 per month, while those in the treatment group reduced their monthly attack rate from 10 to between 1.8 and 3 per month.

Fonte:
Brigo B, Serpelloni G, Homoeopathic Treatment of Migraine Berlin Journal on Research in Homoeopathy, 1, 2, March, 1991, 98-106.

Re: RICERCA SCIENTIFICA OMEOPATICA

MessaggioInviato: gio nov 08, 2012 2:18 am
di Dr.Ascani
Homeopathy in Cuban Epidemic Neuropathy: An Open Clinical Trial

In this uncontrolled trial, 15 people suffering from optic endemic neuropathy (group 1) and 16 people suffering from peripheral epidemic neuropathy (group 2) were given homeopathic Carbon sulph and homeopathic Tabacum for 30 days. The subjects were assessed for improvement in neurologic and ophthalmologic tests on commencement and again at 90 days after commencement of the trial. Those in group 1 experienced an averaged improvement of 73% and group 2 of 12.5%.

Fonte:
Cairo J, Elliot BE, Barnouin J, Fleites P, Araoz A, Morales M, Verdura T, Sanchez M, Serrano C, Alvarez JL, Veillard JJ. Homeopathy in Cuban Epidemic Neuropathy: An Open Clinical Trial. British Homoeopathic Journal, 2001, 90, 150-157.

Re: RICERCA SCIENTIFICA OMEOPATICA

MessaggioInviato: gio nov 08, 2012 2:24 am
di Dr.Ascani
TRATTAMENTO OMEOPATICO DEL DANNO CEREBRALE TRAUMATICO LIEVE: UNO STUDIO CLINICO RANDOMIZZATO IN DOPPIO CIECO CON PLACEBO

Conclusioni:
Questo studio suggerisce che l'omeopatia può avere un ruolo nel trattamento del danno cerebrale traumatico lieve persistente. I nostri risultati richiedono una replica indipendente su larga scala.

Abstract
BACKGROUND:
Mild traumatic brain injury (MTBI) affects 750,000 persons in the United States annually. Five to fifteen percent have persistent dysfunction and disability. No effective, standard pharmacological treatment exists specifically for this problem. We designed a pilot research project to study the clinical effectiveness of homeopathic medicine in the treatment of persistent MTBI.
METHOD:
A randomized, double-blind, placebo-controlled trial of 60 patients, with a four-month follow-up (N = 50), was conducted at Spaulding Rehabilitation Hospital (SRH). Patients with persistent MTBI (mean 2.93 years since injury, SD 3.1) were randomly assigned to receive a homeopathic medicine or placebo. The primary outcome measure was the subject-rated SRH-MBTI Functional Assessment, composed of three subtests: a Difficulty with Situations Scale (DSS), a Symptom Rating Scale (SRS), and a Participation in Daily Activities Scale (PDAS). The SRH Cognitive-Linguistic Test Battery was used as the secondary measure.
RESULTS:
Analysis of covariance demonstrated that the homeopathic treatment was the only significant or near-significant predictor of improvement on DSS subtests (P =.009; 95% CI -.895 to -.15), SRS (P =.058; 95% CI -.548 to.01) and the Ten Most Common Symptoms of MTBI (P =.027; 95% CI -.766 to -.048). These results indicate a significant improvement from the homeopathic treatment versus the control and translate into clinically significant outcomes.

CONCLUSIONS:
This study suggests that homeopathy may have a role in treating persistent MTBI. Our findings require large-scale, independent replication.

Fonte:
J Head Trauma Rehabil. 1999 Dec;14(6):521-42.
http://www.ncbi.nlm.nih.gov/pubmed/10671699

Re: RICERCA SCIENTIFICA OMEOPATICA

MessaggioInviato: gio nov 08, 2012 2:27 am
di Dr.Ascani
Preliminary Investigation into the Effectiveness of the Homoeopathic Remedy, Ruta graveolens, in the Treatment of Pain in Plantar Fasciitis

In a randomised double-blind trial, 14 people suffering from plantar fasciitis were given Ruta graveleons 30C or placebo. Those using the Ruta reported a greater level of pain relief than those using placebo.

Fonte:
Clark J, Percivall AA. Preliminary Investigation into the Effectiveness of the Homoeopathic Remedy, Ruta graveolens, in the Treatment of Pain in Plantar Fasciitis. British Journal of Podiatry, 2000, 3, 3, 81- 85.

Re: RICERCA SCIENTIFICA OMEOPATICA

MessaggioInviato: gio nov 08, 2012 2:29 am
di Dr.Ascani
Complementary Treatment of Varicose Veins.

Over a period of 24 days, the effects of a homoeopathic complex preparation and placebo on varicose veins were tested in a double-blind trial of 61 people suffering from this condition. The homoeopathic complex produced an averaged 44% improvement in the condition while those given the placebo experienced an averaged worsening of the disorder.

Fonte:
Ernst E, Saradeth T, Resch KL, Complementary Treatment of Varicose Veins.. Phebology, 1990, 5, 157-163.

Re: RICERCA SCIENTIFICA OMEOPATICA

MessaggioInviato: gio nov 08, 2012 2:33 am
di Dr.Ascani
A controlled evaluation of a homoeopathic preparation in the treatment of influenza-like syndromes.

Abstract
1. A controlled clinical trial was conducted to assess the effectiveness of a homoeopathic preparation in the treatment of influenza-like syndromes. 2. 237 cases received the test drug and 241 were assigned to placebo. Patients recorded their rectal temperature twice a day, and the presence or absence of five cardinal symptoms (headache, stiffness, lumbar and articular pain, shivers) along with cough, coryza and fatigue. 3. Recovery was defined as a rectal temperature less than 37.5 degrees C and complete resolution of the five cardinal symptoms. 4. The proportion of cases who recovered within 48 h of treatment was greater among the active drug group than among the placebo group (17.1% against 10.3%, P = 0.03). 5. The result cannot be explained given our present state of knowledge, but it calls for further rigorously designed clinical studies.

Fonte:
Br J Clin Pharmacol. 1989 Mar;27(3):329-35.
http://www.ncbi.nlm.nih.gov/pubmed/2655683

Re: RICERCA SCIENTIFICA OMEOPATICA

MessaggioInviato: gio nov 08, 2012 2:37 am
di Dr.Ascani
Influence of potassium dichromate on tracheal secretions in critically ill patients.

Abstract
BACKGROUND:
Stringy, tenacious tracheal secretions may prevent extubation in patients weaned from the respirator. This prospective, randomized, double-blind, placebo-controlled study with parallel assignment was performed to assess the influence of sublingually administered potassium dichromate C30 on the amount of tenacious, stringy tracheal secretions in critically ill patients with a history of tobacco use and COPD.
METHODS:
In this study, 50 patients breathing spontaneously with continuous positive airway pressure were receiving either potassium dichromate C30 globules (group 1) [Deutsche Homoopathie-Union, Pharmaceutical Company; Karlsruhe, Germany] or placebo (group 2). Five globules were administered twice daily at intervals of 12 h. The amount of tracheal secretions on day 2 after the start of the study as well as the time for successful extubation and length of stay in the ICU were recorded.
RESULTS:
The amount of tracheal secretions was reduced significantly in group 1 (p < 0.0001). Extubation could be performed significantly earlier in group 1 (p < 0.0001). Similarly, length of stay was significantly shorter in group 1 (4.20 +/- 1.61 days vs 7.68 +/- 3.60 days, p < 0.0001 [mean +/- SD]).
CONCLUSION:
These data suggest that potentized (diluted and vigorously shaken) potassium dichromate may help to decrease the amount of stringy tracheal secretions in COPD patients.

Fonte:
Chest. 2005 Mar;127(3):936-41.
http://www.ncbi.nlm.nih.gov/pubmed/15764779

Re: RICERCA SCIENTIFICA OMEOPATICA

MessaggioInviato: gio nov 08, 2012 2:39 am
di Dr.Ascani
Trattamento omeopatico dei bambini con Disturbo da Deficit di Attenzione/Iperattività: uno studio in cross over randomizzato, controllato, in doppio cieco con placebo.

CONCLUSIONE: Lo studio suggerisce prove scientifiche dell'efficacia dell'omeopatia nel trattamento del Disturbo da Deficit di Attenzione/Iperattività, in particolare nelle aree delle funzioni comportamentali e cognitive.


Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial.

Abstract
An increasing number of parents turn to homeopathy for treatment of their hyperactive child. Two publications, a randomised, partially blinded trial and a clinical observation study, conclude that homeopathy has positive effects in patients with attention deficit hyperactivity disorder (ADHD). The aim of this study was to obtain scientific evidence of the effectiveness of homeopathy in ADHD. A total of 83 children aged 6-16 years, with ADHD diagnosed using the Diagnostic and Statistical Manual of Mental Disorders-IV criteria, were recruited. Prior to the randomised, double blind, placebo controlled crossover study, they were treated with individually prescribed homeopathic medications. 62 patients, who achieved an improvement of 50% in the Conners' Global Index (CGI), participated in the trial. Thirteen patients did not fulfill this eligibility criterion (CGI). The responders were split into two groups and received either verum for 6 weeks followed by placebo for 6 weeks (arm A), or vice-versa (arm B). At the beginning of the trial and after each crossover period, parents reported the CGI and patients underwent neuropsychological testing. The CGI rating was evaluated again at the end of each crossover period and twice in long-term follow-up. At entry to the crossover trial, cognitive performance such as visual global perception, impulsivity and divided attention, had improved significantly under open label treatment (P<0.0001). During the crossover trial, CGI parent-ratings were significantly lower under verum (average 1.67 points) than under placebo (P =0.0479). Long-term CGI improvement reached 12 points (63%, P <0.0001). CONCLUSION: The trial suggests scientific evidence of the effectiveness of homeopathy in the treatment of attention deficit hyperactivity disorder, particularly in the areas of behavioural and cognitive functions.

Eur J Pediatr. 2005 Dec;164(12):758-67. Epub 2005 Jul 27.
http://www.ncbi.nlm.nih.gov/pubmed/16047154

Re: RICERCA SCIENTIFICA OMEOPATICA

MessaggioInviato: gio nov 08, 2012 2:42 am
di Dr.Ascani
The homoeopathic treatment of otitis media in children--comparisons with conventional therapy.

La cura omeopatica dell' otite media nei bambini - confronto con la terapia convenzionale.
Il gruppo A ha ricevuto un unico rimedio omeopatico (Aconitum napellus, Apis mellifica, Belladonna, Capsicum, Chamomilla, Kalium bichromicum, Lachesis, Lycopodium, Mercurius solubilis, Okoubaka, Pulsatilla, Silicea),
il gruppo B ha ricevuto gocce nasali, antibiotici, mucolitici e/o antipiretici.

Lo studio ha coinvolto 103 bambini nel gruppo A (trattati con l'omeopatia) e 28 bambini nel gruppo B (trattati con le terapie convenzionali) tra i 6 mesi e gli 11 anni.

Il 70,7% dei bambini del gruppo A non ha avuto nessuna ricaduta e il 29,3% ha avuto un massimo di 3 ricadute nell'arco di un anno.
Nel gruppo B il 56,6% non ha avuto nessuna ricaduta mentre il 43,5% ha avuto fino a un massimo di 6 ricadute nell'arco di un anno.


Dei 103 bambini del gruppo A solo 5 hanno fatto poi ricorso agli antibiotici mentre nei restanti 98 si è arrivati a guarigione solo con la cura omeopatica. Nessuna sequela permanente si è osservata in entrambi i gruppi.

Abstract
In a prospective observational study carried out by 1 homoeopathic and 4 conventional ENT practitioners, the 2 methods of treating acute pediatric otitis media were compared. Group A received treatment with homoeopathic single remedies (Aconitum napellus, Apis mellifica, Belladonna, Capsicum, Chamomilla, Kalium bichromicum, Lachesis, Lycopodium, Mercurius solubilis, Okoubaka, Pulsatilla, Silicea), whereas group B received nasal drops, antibiotics, secretolytics and/or antipyretics. The main outcome measures were duration of pain, duration of fever, and the number of recurrences after 1 year, whereby alpha < 0.05 was taken as significance level. The secondary measures were improvement after 3 hours, results of audiometry and tympanometry, and necessity for additional therapy. These parameters were only considered descriptively. The study involved 103 children in group A and 28 children in group B, aged between 6 months and 11 years in both groups. For duration of pain, the median was 2 days in group A and 3 days in group B. For duration of therapy, the median was 4 days in group A and 10 days in group B: this is due to the fact that antibiotics are usually administered over a period of 8-10 days, whereas homoeopathics can be discontinued at an earlier stage once healing has started. Of the children treated, 70.7% were free of recurrence within a year in group A and 29.3% were found to have a maximum of 3 recurrences. In group B, 56.5% were free of recurrence, and 43.5% had a maximum of 6 recurrences. Out of the 103 children in group A, 5 subsequently received antibiotics, though homoeopathic treatment was carried through to the healing stage in the remaining 98. No permanent sequels were observed in either group.

Fonte:
Int J Clin Pharmacol Ther. 1997 Jul;35(7):296-301.
http://www.ncbi.nlm.nih.gov/pubmed/9247843